Trial NCT01278758

View at ClinicalTrials.gov 
Org. Study IDs: CASA404A2109
Secondary IDs: 2009-017159-88

Last trial update was posted on 2020-12-09

MeSH Interventions

Vadimezan

MeSH Conditions

Neoplasm Metastasis Renal Insufficiency

Other Conditions

Metastatic Cancer

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID